Ketamine Attenuates Delirium After Cardiac Surgery With Cardiopulmonary Bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 23, Issue 5, 2009, Pages 651-657

  Hudetz, Judith A ^a   Patterson, Kathleen M ^a   Iqbal, Zafar ^a   Gandhi, Sweeta D ^a   Byrne, Alison J ^a   Hudetz, Anthony G ^a   Warltier, David C ^a   Pagel, Paul S ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cardiac surgery; cardiopulmonary bypass; cognitive dysfunction; delirium; ketamine

Indexed keywords

C REACTIVE PROTEIN; ETOMIDATE; FENTANYL; KETAMINE; PLACEBO;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DELIRIUM; DRUG EFFECT; HEART SURGERY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DELIRIUM; HUMANS; INFLAMMATION MEDIATORS; KETAMINE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 67651203271     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2008.12.021     Document Type: Article

References (36)

1. Sharma P.T., Sieber F.E., Zakriya K.J., et al. Recovery room delirium predicts postoperative delirium after hip-fracture repair. Anesth Analg 101 (2005) 1215-1220
2. Levkoff S.E., Evans D.A., Liptzin B., et al. Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med 152 (1992) 334-340
3. Marcantonio E.R., Goldman L., Mangione C.M., et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA 271 (1994) 134-139
4. Williams-Russo P., Urquhart B.L., Sharrock N.E., et al. Postoperative delirium: Predictors and prognosis in elderly orthopedic patients. J Am Geriatr Soc 40 (1992) 759-767
5. O'Keeffe S.T., and Ni Chonchubhair A. Postoperative delirium in the elderly. Br J Anaesth 73 (1994) 673-687
6. van der Mast R.C., van den Broek W.W., Fekkes D., et al. Incidence of and preoperative predictors for delirium after cardiac surgery. J Psychosom Res 46 (1999) 479-483
7. Litaker D., Locala J., Franco K., et al. Preoperative risk factors for postoperative delirium. Gen Hosp Psychiatry 23 (2001) 84-89
8. Proescholdt M., Heimann A., and Kempski O. Neuroprotection of S(+) ketamine isomer in global forebrain ischemia. Brain Res 904 (2001) 245-251
9. Engelhard K., Werner C., Eberspacher E., et al. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 96 (2003) 524-531
10. Reeker W., Werner C., Mollenberg O., et al. High-dose S(+)-ketamine improves neurological outcome following incomplete cerebral ischemia in rats. Can J Anaesth 47 (2000) 572-578
11. Kolenda H., Gremmelt A., Rading S., et al. Ketamine for analgosedative therapy in intensive care treatment of head-injured patients. Acta Neurochir (Wien) 138 (1996) 1193-1199
12. Miyamoto E., Nakao S., Tomimoto H., et al. Ketamine attenuates hypocapnia-induced neuronal damage in the caudoputamen in a rat model of chronic cerebral hypoperfusion. Neurosci Lett 354 (2004) 26-29
13. Nimkoff L., Quinn C., Silver P., et al. The effects of intravenous anesthetics on intracranial pressure and cerebral perfusion pressure in two feline models of brain edema. J Crit Care 12 (1997) 132-136
14. Himmelseher S., Pfenninger E., and Georgieff M. The effects of ketamine-isomers on neuronal injury and regeneration in rat hippocampal neurons. Anesth Analg 83 (1996) 505-512
15. Laffey J.G., Boylan J.F., and Cheng D.C. The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology 97 (2002) 215-252
16. Hudetz J.A., Iqbal Z., Gandhi S.D., et al. Ketamine attenuates postoperative cognitive dysfunction one week after cardiac surgery (2008), American Society of Anesthesiologists, Orlando, FL A826
17. Ewing J.A. Detecting alcoholism. The CAGE questionnaire. JAMA 252 (1984) 1905-1907
18. Bergeron N., Dubois M.J., Dumont M., et al. Intensive Care Delirium Screening Checklist: Evaluation of a new screening tool. Intensive Care Med 27 (2001) 859-864
19. Hachinski V., and Munoz D. Vascular factors in cognitive impairment-Where are we now?. Ann N Y Acad Sci 903 (2000) 1-5
20. Schwartz M., Creasey H., Grady C.L., et al. Computed tomographic analysis of brain morphometrics in 30 healthy men, aged 21 to 81 years. An Neurol 17 (1985) 146-157
21. Pakkenberg B., and Gundersen H.J. Neocortical neuron number in humans: Effect of sex and age. J Comp Neurol 384 (1997) 312-320
22. Simic G., Kostovic I., Winblad B., et al. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J Comp Neurol 379 (1997) 482-494
23. Morrison J.H., and Hof P.R. Life and death of neurons in the aging brain. Science 278 (1997) 412-419
24. Yaffe K., Lindquist K., Penninx B.W., et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61 (2003) 76-80
25. Schmidt R., Schmidt H., Curb J.D., et al. Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52 (2002) 168-174
26. Bartoc C., Frumento R.J., Jalbout M., et al. A randomized, double-blind, placebo-controlled study assessing the anti-inflammatory effects of ketamine in cardiac surgical patients. J Cardiothorac Vasc Anesth 20 (2006) 217-222
27. Slogoff S., Allen G.W., Wessels J.V., et al. Clinical experience with subanesthetic ketamine. Anesth Analg 53 (1974) 354-358
28. Ely E.W., Shintani A., Truman B., et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291 (2004) 1753-1762
29. Trzepacz P.T. Is there a final common neural pathway in delirium?. Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 5 (2000) 132-148
30. Meldrum B.S. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J Nutr 130 (2000) 1007S-1015S
31. Morrison D.C., and Ryan J.L. Endotoxins and disease mechanisms. Annu Rev Med 38 (1987) 417-432
32. Taggart D.P., Sundaram S., McCartney C., et al. Endotoxemia, complement, and white blood cell activation in cardiac surgery: A randomized trial of laxatives and pulsatile perfusion. Ann Thorac Surg 57 (1994) 376-382
33. Sakai T., Ichiyama T., Whitten C.W., et al. Ketamine suppresses endotoxin-induced NF-kappaB expression. Can J Anaesth 47 (2000) 1019-1024
34. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 14 (1996) 649-683
35. Kawasaki T., Ogata M., Kawasaki C., et al. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 89 (1999) 665-669
36. Abelson K.S., Goldkuhl R.R., Nylund A., et al. The effect of ketamine on intraspinal acetylcholine release: Involvement of spinal nicotinic receptors. Eur J Pharmacol 534 (2006) 122-128